Follicopeptide is a patented peptide developed for adults experiencing visible hair thinning. The ingredient is designed to support the appearance of fuller-looking hair and help maintain healthy-looking hair over time.

Follicopeptide Gel Serum has been launched as a premium cosmetic product incorporating the patented peptide Follicopeptide. The formulation is a water-free gel serum developed specifically for leave-on scalp use and delivered in an airless applicator for precise and hygienic application.

Key benefits:

  • Patented peptide technology
  • Demonstrated cosmetic improvement in the appearance of hair density with consistent use
  • Hormone-independent 
  • Suitable for both men and women
  • Once daily application

The market

Hair loss affects both men and women. Data shows that as much as 50% of all adults globally suffer from hair loss during their lifetime. Currently, there are only a few products on the market that enhances hair growth. These have limited effect, only a small percentage of those who use the product respond to the treatment, they cannot be used by women in effective doses, and cause side effects such as impotence and hair growth in unwanted places.

When it comes to products that enhances eyelashes, Follicopeptide has great potential in the global market, especially since most of the leading products on the market contain prostaglandin analogues as the active component. The EU's Scientific Committee on Consumer Safety (SCCS) has announced its concerns about the safety of prostaglandin analogues when used in cosmetic products near the eye. The global market size for eyelash serum is estimated to 770 million US dollars and for eyebrows 289 million US dollars.

$8 billion

Estimated market value for hair products

$770 million

Estimated market value for eyelash serums

$289 million

Estimated market value for eyebrow serums

Plans 2026

  • Continue onboarding new commercial partners, while enhancing the support to existing customers
  • Launch complimentary product to Follicopeptide® Gel serum (upphöjt ® förstås)
  • Continued production scale-up
  • Extend product portfolio into adjacent cosmetic application ares (eyelash/eyebrow)
  •  

How it works

Follicopeptide is a modified segment of osteopontin – a natural human protein essential for healthy hair growth. It activates key processes in and around the hair follicle by stimulating stem cells, promoting new blood vessel growth, and supporting the surrounding tissue.

Androgenetic alopecia, the most common form of hair loss, occurs when hair follicles gradually miniaturise and become inactive, often due to reduced blood flow. Follicopeptide revitalises blood vessels around the follicle, enhancing growth and follicle health.

Follicopeptide

Progression of androgenic alopecia

Clinically validated

Clinical studies including more than 300 participants with androgenic alopecia demonstrated that Follicopeptide, applied once daily, resulted in remarkable growth of new hairs in individuals with a hair density of less than 255 hairs per square centimeter after just four months.

Background

Follicopeptide was developed by Professor Anna Hultgårdh Nilsson, Lund University in collaboration with LU Bioscience AB. Furthermore, Professor Jan Nilsson is active in progressing the mode-of-action of Follicopeptide at Lund University and in collaboration with Shanghai Changzheng Hospital, China.

Interested in partnering with us?

We welcome conversations with potential partners interested in bringing this innovation to their markets. Our flexible partnership models range from ingredient supply to ready-to-market formats. We’re actively exploring licensing, distribution and go-to-market strategies in key regions.

Get in touch